Alcobra IPO Info
Company Name: Alcobra
Stock Symbol: ADHD
Exchange: NASDAQ
Status: Priced
IPO Date: 5/22/2013
IPO Price:
8.00 (
125.00%)
Underwriters
Aegis Capital
Amount of Offering: N/A
Number of Shares Offered: 3.125 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Alcobra Ltd. is an emerging biopharmaceutical company primarily focused on the development and commercialization of a proprietary drug, MG01CI, to treat Attention Deficit Hyperactivity Disorder. MG01CI has completed Phase II studies to treat Attention Deficit Hyperactivity Disorder. The company was founded in 2008 and is headquartered in Tel Aviv, Israel.
News Headlines
